Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: Use of ionised and total/ionised calcium

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 8, 2006, Pages 962-966

  Bakker, Andries J ^a,c   Boerma, E Christiaan ^b   Keidel, Halbe ^a   Kingma, Peter ^b   Van Der Voort, Peter H J ^b  

^a Clin Chem Lab   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

^c Klinisch Chemisch Laboratorium   (Netherlands)

Author keywords

Catot Ca2+ ratio; Citrate; Citrate intoxication; Continuous venovenous haemofiltration; Ionised calcium; Receiver operating characteristic (ROC) curve analysis

Indexed keywords

CITRIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; FEMALE; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; IONIZATION; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TEACHING HOSPITAL;

AGED; ANTICOAGULANTS; CALCIUM; CITRIC ACID; CRITICAL ILLNESS; FEMALE; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; OVERDOSE; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 33746608575     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.164     Document Type: Article

References (27)

1. Gibney RT, Stollery DE, Lefebvre RE, Sharun CJ, Chan P. Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness. Can Med Assoc J 1988;139:861-6.
2. Ronco C. Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol 1993;40:187-98.
3. Favre H, Martin PY, Stoermann C. Anticoagulation in continuous extracorporeal renal replacement therapy. Semin Dial 1996;9:112-8.
4. Flanigan MJ, VonBrecht J, Freeman RM, Lim VS. Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low dose heparin and citrate anticoagulation. Am J Kidney Dis 1987;9:147-53.
5. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999;55:1991-7.
6. Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT. Regional citrate anticoagulation in continuous venous hemofiltration. Am J Kidney Dis 2000;35:802-11.
7. Mitchell A, Daul AE, Beiderlinden M, Schäfers RF, Heemann U, Kribben A, et al. A new system for regional citrate anticoagulation in continuous venous hemofiltration (CVVHD). Clin Nephrol 2003;59:106-14.
8. Dorval M, Madore F, Courteau S, Lablanc M. A novel citrate anticoagulation regimen for continuous venous hemofiltration. Intensive Care Med 2003;29:1186-9.
9. Mehta TL, McDonald BR, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months. Contrib Nephrol 1991;93:210-4.
10. Gabutti, L, Marone C, Colucci G, Duchini F, Schönholzer C. Citrate anticoagulation in continuous venovenous hemofiltration: a metabolic challenge. Intensive Care Med 2002;28:1419-25.
11. Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, Wagner O, et al. Effect of anticoagulation on membrane interactions during hemodialysis. Kidney Int 1999;56:1578-83.
12. Pinnick RV, Wiegman TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983;308:258-61.
13. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003;31:2450-5.
14. Meier-Krieske HU, Finkel KW, Gitomer JJ, DuBose TD. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999;33:E8.
15. Apsner R, Schwarzenhofer M, Derfler K, Zauner C, Ratheiser K, Kranz A. Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 1997;109:123-7.
16. Janssen M, Huijgens P, Bouman A, Oe P, Van der Meulen J. Citrate anticoagulation and divalent cations in hemodialysis. Blood Purif 1994;12:308-16.
17. Meier-Krieske HU, Gitomer J, Finkel K, DuBose T. Increased total to ionised calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001;29:748-52.
18. Slomp J, van der Voort PH, Gerritsen RT, Berk JA, Bakker AJ. Albumin-adjusted calcium is not suitable for the diagnosis of hyper- and hypocalcemia in the critically ill. Crit Care Med 2003;31:1389-93.
19. Möllering H, Gruber W. Determination of citrate with citrate lyase. Anal Biochem 1966;17:369-76.
20. McWhinney BC, Cowley DM, Chalmers AM. An automated method for measuring plasma citrate without protein precipitation. Clin Chem 1985;31:1578-9.
21. Borland WW, Ferguson JC, Dryburgh FJ. A fast automated method for measuring serum and urine citrate. Ann Clin Biochem 1989;26:286-8.
22. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
23. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
24. Diaz J, Acosta F, Parrilla P, Sansano T, Bento M, Cura S, et al. Citrate intoxication and blood concentration of ionised calcium in liver transplantation. Transplant Proc 1994;26:3669-70.
25. Diaz J, Acosta F, Parrilla P, Sansano T, Contreras RF, Bueno FS, et al. Correlation among ionised calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem 1995;28:315-7.
26. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuos arteriovenous hemodialysis in critically ill patients. Kidney Int 1990;38:976-81.
27. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001;60:370-4.